Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
7 studies found for:    "children's medical center dallas" | allergy
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Condition: Peanut Allergy
Interventions: Biological: Viaskin Peanut 50 mcg;   Biological: Viaskin Peanut 100 mcg;   Biological: Viaskin Peanut 250 mcg;   Biological: Viaskin Placebo
2 Completed Safe Administration of Flu Vaccine to Egg Allergic Children
Condition: Egg Allergy
Intervention: Biological: Trivalent Influenza Vaccine
3 Active, not recruiting Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT
Condition: Peanut Allergy
Intervention: Biological: peanut protein capsule
4 Enrolling by invitation Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children
Condition: Peanut Allergy
Intervention: Biological: Viaskin Peanut 250 mcg
5 Completed Understanding How the Immune System Responds to Viruses in Peanut Allergic Children Undergoing Peanut Oral Immunotherapy
Condition: Peanut Allergy
Intervention: Other: Peanut flour
6 Enrolling by invitation Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using (CPNA) Peanut OIT Safety Follow-On Study
Condition: Peanut Allergy
Intervention: Biological: Peanut protein capsule
7 Unknown  Dilute Bleach Baths in Pediatric Patients With Atopic Dermatitis
Condition: Moderate to Severe Atopic Dermatitis
Interventions: Other: Dilute bleach baths;   Other: Water

Indicates status has not been verified in more than two years